NCT01103700

Brief Summary

The purpose of the study is to compare the quality of dying and death of terminal cancer patients from the perspectives of medical staff and main care giver (family). The hypothesis is that their view points will be different.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2010

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 13, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 15, 2010

Completed
16 days until next milestone

Study Start

First participant enrolled

May 1, 2010

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2010

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2010

Completed
Last Updated

April 15, 2010

Status Verified

April 1, 2010

Enrollment Period

2 months

First QC Date

April 13, 2010

Last Update Submit

April 14, 2010

Conditions

Cancer

Keywords

Quality of dying and death of terminal cancer patients

Eligibility Criteria

Age20 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Main care givers of deceased patients

You may qualify if:

  • Cognitively intact.
  • Contact with the patient in the last month.

You may not qualify if:

  • Cognitively not intact.
  • No contact with the patient in the last month.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, Taiwan, Taiwan, Taiwan

Location

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Shao-Yi Cheng, MD, MSc

    National Taiwan University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Shao-Yi Cheng, MD, MSc

CONTACT

886-2-23123456shaoyi2140@yahoo.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 13, 2010

First Posted

April 15, 2010

Study Start

May 1, 2010

Primary Completion

July 1, 2010

Study Completion

August 1, 2010

Last Updated

April 15, 2010

Record last verified: 2010-04

Locations

TW(1)